This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Singla S , Papavasiliou P , Powers B , Gaughan J , von Mehren M , Watson JC , Farma JM
Challenges in the treatment of angiosarcoma: a single institution experience
Am J Surg. 2014 Aug;208(2) :254-9
PMID: 24811931 URL: http://www.ncbi.nlm.nih.gov/pubmed/24811931
AbstractBACKGROUND: Angiosarcomas are rare tumors that carry poor prognosis. Because of insidious growth rate, the diagnosis is often difficult and delayed. METHODS: Between 1990 and 2011, 72 (41 female, 31 male) patients were treated at our institution. Pathologic confirmation was obtained and multiple prognostic factors were evaluated for survival. RESULTS: Forty-four cases were sporadic and 28 cases were secondary. In the sporadic group, 16 (36%) patients had increased sun exposure, while in the secondary group, the majority (n = 23, 82%) of patients had prior exposure to radiation. The latent period between radiation exposure and diagnosis was predictive of survival (P = .037). Presentation was delayed by more than 3 months in 41% of patients. The majority of men developed head and neck angiosarcomas (n = 15, 48.5%), while women developed breast angiosarcomas (n = 21, 51%). Median survival was prolonged in patients treated initially with surgery. CONCLUSIONS: A delay in the diagnosis of angiosarcoma can affect survival. Clinical suspicion and prompt diagnosis are essential for successful multimodal therapy. Initial surgical resection with adjuvant chemotherapy provides survival advantage.
Notes1879-1883 Singla, Smit Papavasiliou, Pavlos Powers, Benjamin Gaughan, John von Mehren, Margaret Watson, James C Farma, Jeffrey M Journal Article United States Am J Surg. 2014 Aug;208(2):254-9. doi: 10.1016/j.amjsurg.2014.01.007. Epub 2014 Apr 15.